As filed with the Securities and Exchange Commission on December 13, 2006 | Registration No. 333- |
Delaware
|
20-4121393
|
(State
or Other Jurisdiction of Incorporation or
Organization)
|
(I.R.S.
Employer Identification
No.)
|
Title
of Securities to be
Registered
|
Amount
to be Registered
|
Proposed
Maximum
Offering
Price
Per
Share (1)
|
Proposed
Maximum
Aggregate
Offering
Price
|
Amount
of
Registration
Fee
|
Common
Stock, $0.001 par value per share
|
199,286
(2)
|
$11.98
|
$2,386,625
|
$256
|
(1)
|
Estimated
solely for the purpose of computing the registration fee pursuant
to Rule
457 under the Securities Act of 1933, as amended, based on the weighted
average exercise price of the outstanding options.
|
(2)
|
Represents
shares subject to issuance upon the exercise of stock options outstanding
under the Q-RNA 2002 Stock Incentive Plan and assumed by the Registrant
on
November 29, 2006 pursuant to an Agreement and Plan of Merger by
and among
Registrant, wholly-owned subsidiaries of Registrant, Q-RNA, Inc.
and a
representative of the Q-RNA, Inc.
securityholders.
|
Item
1.
|
Plan
Information*
|
Item
2.
|
Registrant
Information and Employee Plan Annual Information*
|
* |
Information
about the Registrant required by Part I, Items 1 and 2 to be contained
in
a Section 10(a) prospectus is omitted from the Registration Statement
in
accordance with Rule 428 under the Securities
Act of 1933, as amended (the “Securities Act”), and the Note to Part I of
Form S-8.
|
Item 3. |
Incorporation
of Documents by
Reference
|
1.
|
The
Registrant’s Annual Report on Form 10-KSB for the fiscal year ended
December 31, 2005;
|
2.
|
The
description of Registrant’s Common Stock contained in Registrant’s
Registration Statement on Form 8-A filed with the Commission on April
3,
2006 under Section 12(g) of the Securities Exchange Act of 1934,
as
amended, including any amendment or report filed for the purposes
of
updating such description; and
|
3.
|
All
other reports filed pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”) since the end of the
fiscal year covered by the above referred to annual
report.
|
Item 4. |
Description
of
Securities
|
Item 5. |
Interests
of Named Experts and
Counsel
|
Item 6. |
Indemnification
of Officers and
Directors
|
Item 7. |
Exemption
from Registration
Claimed.
|
Item 8. |
Exhibits.
|
Incorporated
by Reference
|
|||||
Exhibit
Number
|
Exhibit
Description
|
Form
|
Exhibit
|
Filing
Date
|
Filed
Herewith
|
5.01
|
Opinion
of Arent Fox PLLC
|
X
|
|||
10.01
|
2002
Q-RNA, Inc. Stock Incentive Plan
|
X
|
|||
23.01
|
Consent
of Independent Registered Public Accounting Firm
|
X
|
|||
23.02
|
Consent
of Arent Fox PLLC (filed as part of Exhibit 5.01)
|
X
|
|||
24.01
|
Power
of Attorney (Included on Signature Page)
|
X
|
Item 9. |
Undertakings
|
NEURO-HITECH, INC. | ||
|
|
|
By: | /s/ David Barrett | |
David Barrett
Chief Financial Officer
|
||
Signature
|
Title
|
Date
|
Reuben
Seltzer
|
Chief
Executive Officer and Director (principal executive
officer)
|
December
12, 2006
|
/s/
David
Barrett
David
Barrett
|
Chief
Financial Officer (principal accounting
and financial officer)
|
December
12, 2006
|
John
Abernathy
|
Director
|
December
__, 2006
|
/s/
Mark
Auerbach
Mark
Auerbach
|
Director
|
December
12, 2006
|
/s/
David
Dantzker
David
Dantzker
|
Director
|
December
12, 2006
|
Alan
Kestenbaum
|
Director
|
December
__, 2006
|
/s/
William
McIntosh
William
McIntosh
|
Director
|
December
12, 2006
|
Incorporated
by Reference
|
|||||
Exhibit
Number
|
Exhibit
Description
|
Form
|
Exhibit
|
Filing
Date
|
Filed
Herewith
|
5.01
|
Opinion
of Arent Fox PLLC
|
X
|
|||
10.01
|
2002
Q-RNA, Inc. Stock Incentive Plan
|
X
|
|||
23.01
|
Consent
of Independent Registered Public Accounting Firm
|
X
|
|||
23.02
|
Consent
of Arent Fox PLLC (filed as part of Exhibit 5.01)
|
X
|
|||
24.01
|
Power
of Attorney (Included on Signature Page)
|
X
|